Therapeutic Efficacy and Biodistribution of Paclitaxel-Bound Amphiphilic Cyclodextrin Nanoparticles: Analyses in 3D Tumor Culture and Tumor-Bearing Animals In Vivo

The uniqueness of paclitaxel’s antimitotic action mechanism has fueled research toward its application in more effective and safer cancer treatments. However, the low water solubility, recrystallization, and side effects hinder the clinical success of classic paclitaxel chemotherapy. The aim of this...

Full description

Bibliographic Details
Main Authors: Gamze Varan, Cem Varan, Süleyman Can Öztürk, Juan M. Benito, Güneş Esendağlı, Erem Bilensoy
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Nanomaterials
Subjects:
Online Access:https://www.mdpi.com/2079-4991/11/2/515
_version_ 1797396104264810496
author Gamze Varan
Cem Varan
Süleyman Can Öztürk
Juan M. Benito
Güneş Esendağlı
Erem Bilensoy
author_facet Gamze Varan
Cem Varan
Süleyman Can Öztürk
Juan M. Benito
Güneş Esendağlı
Erem Bilensoy
author_sort Gamze Varan
collection DOAJ
description The uniqueness of paclitaxel’s antimitotic action mechanism has fueled research toward its application in more effective and safer cancer treatments. However, the low water solubility, recrystallization, and side effects hinder the clinical success of classic paclitaxel chemotherapy. The aim of this study was to evaluate the in vivo efficacy and biodistribution of paclitaxel encapsulated in injectable amphiphilic cyclodextrin nanoparticles of different surface charges. It was found that paclitaxel-loaded amphiphilic cyclodextrin nanoparticles showed an antitumoral effect earlier than the drug solution. Moreover, the blank nanoparticles reduced the tumor growth with a similar trend to the paclitaxel solution. At 24 h, the nanoparticles had not accumulated in the heart and lungs according to the biodistribution assessed by in vivo imaging. Therefore, our results indicated that the amphiphilic cyclodextrin nanoparticles are potentially devoid of cardiac toxicity, which limits the clinical use and commercialization of certain polymeric nanoparticles. In conclusion, the amphiphilic cyclodextrin nanoparticles with different surface charge increased the efficiency of paclitaxel in vitro and in vivo. Cyclodextrin nanoparticles could be a good candidate vehicle for intravenous paclitaxel delivery.
first_indexed 2024-03-09T00:46:29Z
format Article
id doaj.art-33f08c038c9949d1830a4b22740bf951
institution Directory Open Access Journal
issn 2079-4991
language English
last_indexed 2024-03-09T00:46:29Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Nanomaterials
spelling doaj.art-33f08c038c9949d1830a4b22740bf9512023-12-11T17:28:25ZengMDPI AGNanomaterials2079-49912021-02-0111251510.3390/nano11020515Therapeutic Efficacy and Biodistribution of Paclitaxel-Bound Amphiphilic Cyclodextrin Nanoparticles: Analyses in 3D Tumor Culture and Tumor-Bearing Animals In VivoGamze Varan0Cem Varan1Süleyman Can Öztürk2Juan M. Benito3Güneş Esendağlı4Erem Bilensoy5Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, 06100 Ankara, TurkeyDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, 06100 Ankara, TurkeyResearch and Application Center for Advanced Technologies (HUNITEK), Hacettepe University, 06100 Ankara, TurkeyInstitute for Chemical Research, Consejo Superior de Investigaciones Científicas (CSIC), University of Sevilla, Av. Américo Vespucio 49, 41092 Sevilla, SpainCancer Institute, Department of Basic Oncology, Hacettepe University, 06100 Ankara, TurkeyDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, 06100 Ankara, TurkeyThe uniqueness of paclitaxel’s antimitotic action mechanism has fueled research toward its application in more effective and safer cancer treatments. However, the low water solubility, recrystallization, and side effects hinder the clinical success of classic paclitaxel chemotherapy. The aim of this study was to evaluate the in vivo efficacy and biodistribution of paclitaxel encapsulated in injectable amphiphilic cyclodextrin nanoparticles of different surface charges. It was found that paclitaxel-loaded amphiphilic cyclodextrin nanoparticles showed an antitumoral effect earlier than the drug solution. Moreover, the blank nanoparticles reduced the tumor growth with a similar trend to the paclitaxel solution. At 24 h, the nanoparticles had not accumulated in the heart and lungs according to the biodistribution assessed by in vivo imaging. Therefore, our results indicated that the amphiphilic cyclodextrin nanoparticles are potentially devoid of cardiac toxicity, which limits the clinical use and commercialization of certain polymeric nanoparticles. In conclusion, the amphiphilic cyclodextrin nanoparticles with different surface charge increased the efficiency of paclitaxel in vitro and in vivo. Cyclodextrin nanoparticles could be a good candidate vehicle for intravenous paclitaxel delivery.https://www.mdpi.com/2079-4991/11/2/515tumor targetingcyclodextrinnanoparticlepaclitaxelbiodistributionbreast tumor induced animal model
spellingShingle Gamze Varan
Cem Varan
Süleyman Can Öztürk
Juan M. Benito
Güneş Esendağlı
Erem Bilensoy
Therapeutic Efficacy and Biodistribution of Paclitaxel-Bound Amphiphilic Cyclodextrin Nanoparticles: Analyses in 3D Tumor Culture and Tumor-Bearing Animals In Vivo
Nanomaterials
tumor targeting
cyclodextrin
nanoparticle
paclitaxel
biodistribution
breast tumor induced animal model
title Therapeutic Efficacy and Biodistribution of Paclitaxel-Bound Amphiphilic Cyclodextrin Nanoparticles: Analyses in 3D Tumor Culture and Tumor-Bearing Animals In Vivo
title_full Therapeutic Efficacy and Biodistribution of Paclitaxel-Bound Amphiphilic Cyclodextrin Nanoparticles: Analyses in 3D Tumor Culture and Tumor-Bearing Animals In Vivo
title_fullStr Therapeutic Efficacy and Biodistribution of Paclitaxel-Bound Amphiphilic Cyclodextrin Nanoparticles: Analyses in 3D Tumor Culture and Tumor-Bearing Animals In Vivo
title_full_unstemmed Therapeutic Efficacy and Biodistribution of Paclitaxel-Bound Amphiphilic Cyclodextrin Nanoparticles: Analyses in 3D Tumor Culture and Tumor-Bearing Animals In Vivo
title_short Therapeutic Efficacy and Biodistribution of Paclitaxel-Bound Amphiphilic Cyclodextrin Nanoparticles: Analyses in 3D Tumor Culture and Tumor-Bearing Animals In Vivo
title_sort therapeutic efficacy and biodistribution of paclitaxel bound amphiphilic cyclodextrin nanoparticles analyses in 3d tumor culture and tumor bearing animals in vivo
topic tumor targeting
cyclodextrin
nanoparticle
paclitaxel
biodistribution
breast tumor induced animal model
url https://www.mdpi.com/2079-4991/11/2/515
work_keys_str_mv AT gamzevaran therapeuticefficacyandbiodistributionofpaclitaxelboundamphiphiliccyclodextrinnanoparticlesanalysesin3dtumorcultureandtumorbearinganimalsinvivo
AT cemvaran therapeuticefficacyandbiodistributionofpaclitaxelboundamphiphiliccyclodextrinnanoparticlesanalysesin3dtumorcultureandtumorbearinganimalsinvivo
AT suleymancanozturk therapeuticefficacyandbiodistributionofpaclitaxelboundamphiphiliccyclodextrinnanoparticlesanalysesin3dtumorcultureandtumorbearinganimalsinvivo
AT juanmbenito therapeuticefficacyandbiodistributionofpaclitaxelboundamphiphiliccyclodextrinnanoparticlesanalysesin3dtumorcultureandtumorbearinganimalsinvivo
AT gunesesendaglı therapeuticefficacyandbiodistributionofpaclitaxelboundamphiphiliccyclodextrinnanoparticlesanalysesin3dtumorcultureandtumorbearinganimalsinvivo
AT erembilensoy therapeuticefficacyandbiodistributionofpaclitaxelboundamphiphiliccyclodextrinnanoparticlesanalysesin3dtumorcultureandtumorbearinganimalsinvivo